metformin has been researched along with D-fructopyranose in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.89) | 18.7374 |
1990's | 4 (7.55) | 18.2507 |
2000's | 14 (26.42) | 29.6817 |
2010's | 21 (39.62) | 24.3611 |
2020's | 13 (24.53) | 2.80 |
Authors | Studies |
---|---|
Bartosiewicz, W; Czyzyk, A; Lao, B; Orlowska, K; Szczepanik, Z | 1 |
Bhanot, S; McNeill, JH; Verma, S | 2 |
Hector, R; Hobensack, CK; Luo, J; Quan, J; Reaven, GM; Sullivan, C; Tsai, J | 1 |
Faure, P; Favier, A; Halimi, S; Richard, MJ; Rossini, E; Wiernsperger, N | 1 |
Ewart, HS; Severson, D; Shimoni, Y | 1 |
Chang, CT; Chen, CC; Chen, RH; Sheen, LY; Shih, HC; Wang, HJ; Wang, TY | 1 |
Anuradha, CV; Anurag, P | 1 |
Sanders, TA; Taylor, D; Werneke, U | 1 |
Baret, G; Dalmaz, Y; Géloën, A; Grassi-Kassisse, D; Peyronnet, J; Wiernsperger, N | 1 |
Anuradha, CV; Srividhya, S | 1 |
Anuradha, CV; Ravichandran, MK; Srividhya, S | 1 |
Fitchet, M; Gorska, M; Hamann, A; Masson, E; Moore, R; Sun, X; Toplak, H; Vercruysse, F | 1 |
Gadde, KM; Hollander, P; Leung, A; Rosenstock, J; Strauss, R; Sun, X | 1 |
Barclay, D; Faure, P; Halimi, S; Joyeux-Faure, M | 1 |
Al-Zaman, Y; Aylwin, S | 1 |
Chang, T; Desai, K; Jia, X; Wang, X; Wu, L | 1 |
Kapoor, S | 1 |
Anuradha, CV; Kannappan, S | 1 |
Ellinger, LK; Ipema, HJ; Stachnik, JM | 1 |
Benhamou, PY; Cottet-Rousselle, C; Fontaine, E; Halimi, S; Lablanche, S; Lamarche, F; Leverve, X | 1 |
Bray, GA; Ryan, DH | 1 |
Chien, KY; Hsu, KF; Hsu, MC; Huang, CC; Kuo, CH | 1 |
Borroni, JS; Boudou, S; Carranza, A; Donoso, AS; Peredo, HA; Puyó, AM; Santander, Y | 1 |
Bergheim, I; Bischoff, SC; Kanuri, G; Spruss, A; Stahl, C | 1 |
Bagul, PK; Banerjee, SK; Bastia, T; Chakravarty, S; Madhusudana, K; Matapally, S; Middela, H; Padiya, R; Reddy, BR | 1 |
Andrés-Hernando, A; Cicerchi, C; Garcia, G; Hodges, RS; Hunter, B; Ishimoto, T; Johnson, RJ; Lanaspa, MA; Li, N; Mant, CT; Rivard, CJ; Roncal-Jimenez, CA; Sánchez-Lozada, LG; Thomas, J | 1 |
Adeli, K; Ji, J; Jiang, B; Liu, L; Lu, J; Meng, H; Meng, QH; Randell, E; Wang, D | 1 |
Huang, F; Kou, J; Li, J; Liu, B; Liu, K; Qi, L; Sun, Y; Wang, M; Xiao, N | 1 |
Curtin, CR; Ford, L; Heald, D; Manitpisitkul, P; Shalayda, K; Wang, SS | 1 |
Bagul, PK; Banerjee, SK; Chakravarty, S; Jhelum, P; Kaur, G; Kumar, A; Kumar, KP; Maitra, S; Reddy, BR | 1 |
Antu, KA; Mishra, A; Nair, A; Raghu, KG; Riya, MP; Srivastava, AK | 1 |
Andrade, C | 1 |
Agius, L; Al-Oanzi, ZH; Alshawi, A; Arden, C; Fountana, S; Moonira, T; Patman, G; Petrie, JL; Reeves, HL; Tudhope, SJ | 1 |
Aguirre, JI; Cortizo, AM; Felice, JI; McCarthy, AD; Schurman, L; Sedlinsky, C | 1 |
Kosuru, R; Singh, S | 1 |
Centurión, D; Gutiérrez-Lara, EJ; Navarrete-Vázquez, G; Sánchez-López, A | 1 |
Al-Salami, H; Brook, E; Fimognari, N; Lam, V; Mamo, JC; Mooranian, A; Nesbit, M; Takechi, R | 1 |
Abd El Latif, HA; AinShoka, AA; El Shazly, KA; Zayed, EA | 1 |
Latiff, AA; Mardiana, AA; Sahema, ZCT; Santhana, RL; Syed Ahmad Fuad, SB; Zaidun, NH | 1 |
Bagul, PK; Banerjee, SK; Rai, RC | 1 |
Amadi, JA; Amadi, PU; Njoku, UC; Osuoha, JO | 1 |
Arunsak, B; Chattipakorn, N; Chattipakorn, SC; Chunchai, T; Jaiwongkam, T; Jinawong, K; Pongkan, W; Pratchayasakul, W; Tokuda, M | 1 |
Gryciuk, ME; Maciejczyk, M; Mil, KM; Pawlukianiec, C; Zalewska, A; Żendzian-Piotrowska, M; Ładny, JR | 1 |
Arita, K; Ito, T; Kambe, Y; Kasamo, Y; Kawahara, KI; Kikuchi, K; Maruyama, I; Otsuka, S; Takada, S; Yamakuchi, M; Yoshimoto, K | 1 |
Ahmed, HMS; Ibrahim, IAAE; Ibrahim, WS; Mahmoud, AAA; Mahmoud, MF | 1 |
Chen, YY; Cheng, PW; Ho, CY; Sun, GC; Tseng, CJ; Wu, TT; Yeh, TC | 1 |
Erukainure, OL; Ijomone, OK; Islam, MS; Msomi, NZ; Olofinsan, KA; Salau, VF | 1 |
Chen, J; Cheng, J; Guan, F; Huang, X; Li, M; Li, Y; Lin, G; Liu, Y; Ma, X; Su, Z; Xie, J; Xu, L; Yu, Q | 1 |
Adeolu, AI; Amobi, CA; Chikezie, CC; Egedigwe-Ekeleme, AC; Eleazu, CO; Eleazu, KC; Igwe, VM; Kalu, AO; Kalu, WO; Kanu, S; Njemanze, CC; Obeten, UN; Obi, V; Odii, BC; Ogunwa, SC; Okoh, PN; Okorie, UC; Onyia, CJ; Onyia, S; Ossai, P; Ozor, G; Ugada, OJ | 1 |
Brown, JD; Donahoo, WT; Hampp, C; Sarayani, A; Winterstein, AG | 1 |
Chen, LM; Cheng, Y; Deng, XQ; Fang, T; Guo, H; Li, T; Qu, JR; Sun, B; Xu, CF | 1 |
Anand, A; Batra, GK; Bhansali, S; Patil, AN; Sharma, S | 1 |
5 review(s) available for metformin and D-fructopyranose
Article | Year |
---|---|
Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
Topics: Amantadine; Antipsychotic Agents; Cimetidine; Cyclobutanes; Fluoxetine; Fructose; Humans; Lactones; Metformin; Nizatidine; Obesity; Orlistat; Topiramate; Weight Gain | 2002 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Topics: Anti-Obesity Agents; Antipsychotic Agents; Fructose; Humans; Hypoglycemic Agents; Metformin; Obesity; Psychotic Disorders; Randomized Controlled Trials as Topic; Topiramate; Weight Gain | 2010 |
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions.
Topics: Anti-Obesity Agents; Antipsychotic Agents; Aripiprazole; Cardiovascular Diseases; Fructose; Humans; Hypoglycemic Agents; Metabolic Syndrome; Metformin; Schizophrenia; Topiramate | 2016 |
Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and
Topics: Acetylcysteine; Animals; Antioxidants; Captopril; Chloramines; Chromans; Fructose; Glucose; Glycosylation; Humans; Metformin; Oxidation-Reduction; Pyruvaldehyde; Serum Albumin, Bovine; Thioctic Acid; Tosyl Compounds; Valsartan | 2021 |
3 trial(s) available for metformin and D-fructopyranose
Article | Year |
---|---|
Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Topiramate; Treatment Outcome; Weight Loss | 2007 |
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
Topics: Adult; Aged; Anti-Obesity Agents; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diet, Reducing; Double-Blind Method; Exercise; Female; Fructose; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Placebos; Safety; Topiramate | 2007 |
Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Fructose; Humans; Hypoglycemic Agents; Male; Metformin; Pioglitazone; Tandem Mass Spectrometry; Thiazolidinediones; Time Factors; Topiramate; Young Adult | 2014 |
45 other study(ies) available for metformin and D-fructopyranose
Article | Year |
---|---|
The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects.
Topics: Adolescent; Adult; Biguanides; Blood Glucose; Buformin; Ethanol; Female; Fructose; Humans; Lactates; Male; Metformin; Middle Aged; Phenformin; Physical Exertion | 1978 |
Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Fructose; Hypertension; Insulin; Male; Metformin; Rats; Rats, Sprague-Dawley | 1994 |
Decreased vascular reactivity in metformin-treated fructose-hypertensive rats.
Topics: Animals; Antihypertensive Agents; Fructose; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Male; Mesenteric Arteries; Metformin; Rats; Rats, Sprague-Dawley | 1996 |
Nongenetic mouse models of non-insulin-dependent diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Sucrose; Disease Models, Animal; Fructose; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Tolbutamide | 1998 |
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.
Topics: Animals; Dietary Carbohydrates; Free Radical Scavengers; Fructose; Hypoglycemic Agents; Insulin; Lipid Peroxides; Male; Metformin; Oxidoreductases; Rats; Rats, Wistar | 1999 |
Insulin resistance and the modulation of rat cardiac K(+) currents.
Topics: Animals; Cells, Cultured; Cycloheximide; Dietary Carbohydrates; Fructose; Heart; Heart Ventricles; Hyperinsulinism; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Resistance; Membrane Potentials; Metformin; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Vanadium Compounds | 2000 |
Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
Topics: Animals; Chromans; Fatty Acids, Nonesterified; Fructose; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Metformin; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Metformin improves lipid metabolism and attenuates lipid peroxidation in high fructose-fed rats.
Topics: Animals; Blood Glucose; Cholesterol; Dietary Carbohydrates; Fatty Acids, Nonesterified; Fructose; Hypoglycemic Agents; Insulin; Kidney; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Metformin; Rats; Rats, Wistar; Triglycerides | 2002 |
Increased intraabdominal adipose tissue mass in fructose fed rats: correction by metformin.
Topics: Adipose Tissue; Animals; Diet; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2002 |
Metformin improves liver antioxidant potential in rats fed a high-fructose diet.
Topics: Animals; Antioxidants; Dietary Carbohydrates; Fructose; Hypoglycemic Agents; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Metformin; Random Allocation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2002 |
Metformin attenuates blood lipid peroxidation and potentiates antioxidant defense in high fructose-fed rats.
Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dietary Sucrose; Fructose; Insulin; Insulin Resistance; Lipid Peroxidation; Metformin; Rats; Rats, Wistar | 2002 |
Comparison of the effects of zinc alone and zinc associated with selenium and vitamin E on insulin sensitivity and oxidative stress in high-fructose-fed rats.
Topics: Animals; Antioxidants; Diet; Dietary Carbohydrates; Fructose; Glucose Clamp Technique; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Metformin; Micronutrients; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Wistar; Selenium; Vitamin E; Zinc | 2007 |
Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
Topics: Animals; Aorta; Dietary Carbohydrates; Fructose; Glutathione; Glycation End Products, Advanced; Hydrogen Peroxide; Hypertension; Hypoglycemic Agents; Lysine; Male; Mesenteric Arteries; Metformin; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyruvaldehyde; Rats; Rats, Sprague-Dawley | 2008 |
Strategies to control antipsychotic-induced weight gain.
Topics: Anti-Obesity Agents; Antipsychotic Agents; Awareness; Body Weight; Bupropion; Clinical Competence; Fructose; Humans; Hypoglycemic Agents; Melatonin; Metformin; Obesity; Topiramate; Treatment Outcome; Weight Gain | 2008 |
Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model.
Topics: Animals; Blood Glucose; Fatty Acids, Nonesterified; Flavonoids; Fructose; Glucose Tolerance Test; Insulin; Insulin Resistance; Liver; Male; Metformin; Phenols; Plant Extracts; Polyphenols; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Quercetin; Rats; Rats, Wistar; Seeds; Triglycerides; Trigonella | 2009 |
Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin.
Topics: Animals; Apoptosis; Biological Transport; Calcium; Cell Death; Cell Line; Cell Survival; Cyclosporine; Fructose; Glucose; Insulin-Secreting Cells; Metformin; Mitochondria; Permeability; Protective Agents; Rats | 2011 |
Drug treatment of obesity.
Topics: Adolescent; Adult; Anti-Obesity Agents; Antidepressive Agents, Second-Generation; Body Weight; Bupropion; Child; Drug Approval; Drug Combinations; Energy Intake; Exenatide; Female; Fructose; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lactones; Male; Metformin; Naltrexone; Narcotic Antagonists; Obesity; Orlistat; Patient Compliance; Peptides; Randomized Controlled Trials as Topic; Sympathomimetics; Topiramate; United States; United States Food and Drug Administration; Venoms | 2011 |
Swim training reduces metformin levels in fructose-induced insulin resistant rats.
Topics: Animals; Fructose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Rats; Rats, Wistar; Swimming | 2012 |
Metformin reduces vascular production of vasoconstrictor prostanoids in fructose overloaded rats.
Topics: Animals; Aorta, Thoracic; Fructose; Male; Mesenteric Arteries; Metabolic Syndrome; Metformin; Oxidation-Reduction; Prostaglandins; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2012 |
Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Topics: Animals; Disease Models, Animal; Endotoxins; Fatty Liver; Fructose; Gene Expression; Hypoglycemic Agents; Insulin Resistance; Liver; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Metformin; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Plasminogen Activator Inhibitor 1; RNA, Messenger; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
Topics: Animals; Ascorbic Acid; Blood Glucose; Body Weight; Catalase; Eating; Fructose; Glucose Tolerance Test; Glutathione; Insulin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Triglycerides; Uric Acid | 2012 |
Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.
Topics: Adenylate Kinase; AMP Deaminase; Animals; Carbon-Carbon Double Bond Isomerases; Enzyme Activation; Fats; Fatty Liver; Fructose; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Isoenzymes; Male; Metformin; Oxidation-Reduction; Rats; Uric Acid | 2012 |
The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats.
Topics: Animals; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Cells, Cultured; Cholesterol; Fatty Acids, Nonesterified; Fructose; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Protective Agents; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Triglycerides; Vascular Access Devices; Wound Healing | 2013 |
Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.
Topics: Adipokines; Adipose Tissue; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aorta; Culture Media, Conditioned; Diet; Fructose; Metformin; NF-kappa B; Palmitic Acid; Rats; Resveratrol; Ribonucleotides; Sirtuin 1; Sodium Salicylate; Stilbenes; Vasodilation | 2014 |
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats.
Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Fructose; Gene Expression Regulation; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Prediabetic State; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2016 |
Symplocos cochinchinensis enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in high energy diet rat model.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Dose-Response Relationship, Drug; Down-Regulation; Dyslipidemias; Ethanol; Fructose; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipogenesis; Liver; Magnoliopsida; Male; Metformin; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats, Sprague-Dawley; Solvents; Time Factors | 2016 |
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
Topics: Active Transport, Cell Nucleus; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Diet, Western; Enzyme Activators; Fructose; Fructosediphosphates; Gene Expression Regulation, Enzymologic; Glucokinase; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatocytes; Hypoglycemic Agents; Male; Metformin; Mice, Inbred C3H; Overweight; Promoter Regions, Genetic; Pyruvate Kinase; Rats, Wistar; Thiazoles | 2017 |
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment.
Topics: Adipocytes; Animals; Bone and Bones; Bone Density; Cell Differentiation; Cells, Cultured; Fructose; Male; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Osteogenesis; Rats; Rats, Wistar | 2017 |
Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats.
Topics: Animals; beta-Cyclodextrins; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2017 |
Pharmacological evaluation of metformin and N-benzylbiguanide, a novel analogue of metformin, on the vasopressor responses to adrenergic system stimulation in pithed rats with fructose-induced insulin resistance.
Topics: Adrenergic Agonists; Animals; Biguanides; Blood Glucose; Blood Pressure; Fructose; Heart Rate; Hemodynamics; Insulin; Insulin Resistance; Male; Metformin; Rats; Rats, Wistar; Receptors, Adrenergic; Sympathetic Nervous System | 2017 |
Probucol prevents blood-brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet.
Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Blood-Brain Barrier; Cerebral Cortex; Cognition; Cognition Disorders; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Fructose; Glial Fibrillary Acidic Protein; Hippocampus; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Male; Maze Learning; Metformin; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Probucol | 2019 |
Improvement of insulin resistance via increase of GLUT4 and PPARγ in metabolic syndrome-induced rats treated with omega-3 fatty acid or l-carnitine.
Topics: Adiposity; Animals; Carnitine; Diet, Carbohydrate Loading; Diet, High-Fat; Dietary Supplements; Fatty Acids, Omega-3; Fructose; Glucose Transporter Type 4; Heart; Hypoglycemic Agents; Insulin Resistance; Intra-Abdominal Fat; Liver; Male; Metabolic Syndrome; Metformin; Myocardium; Organ Size; PPAR gamma; Random Allocation; Rats, Sprague-Dawley | 2018 |
Effects of naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Synergism; Flavanones; Fructose; Hyperglycemia; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Metformin; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin | 2019 |
NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Hypoglycemic Agents; Inflammasomes; Inflammation; Insulin Resistance; Liver; Male; Metformin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Potentiation of incretin hormones and modulation of metabolic enzymes as possible mechanisms behind the insulin sensitizing effects of cabbage-metformin treatment.
Topics: Animal Feed; Animals; Brassica; Diet; Dietary Carbohydrates; Fructose; Hypoglycemic Agents; Incretins; Insulin Resistance; Male; Metformin; Rats; Rats, Wistar | 2021 |
Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats.
Topics: Animals; Cognitive Dysfunction; Diet, High-Fat; Drinking Water; Fructose; Insulin Resistance; Insulins; Metformin; Obesity; Prediabetic State; Rats; Rats, Wistar | 2022 |
1,5-Anhydro-D-fructose Protects against Rotenone-Induced Neuronal Damage In Vitro through Mitochondrial Biogenesis.
Topics: Adenylate Kinase; Animals; Cell Death; Fructose; Gene Silencing; Metformin; Mitochondria; Neurons; Neuroprotective Agents; Organelle Biogenesis; PC12 Cells; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Rats; Rotenone | 2021 |
Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance β-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin.
Topics: Animals; beta-Arrestin 2; Blood Glucose; Diet, High-Fat; Fructose; Glucose; Heart; Insulin; Insulin Resistance; Isoproterenol; Male; Metformin; Mice; Propranolol; Signal Transduction; Ventricular Remodeling | 2021 |
Blocking of SGLT2 to Eliminate NADPH-Induced Oxidative Stress in Lenses of Animals with Fructose-Induced Diabetes Mellitus.
Topics: Animals; Cataract; Diabetes Mellitus; Fructose; Metformin; NADP; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Resveratrol; Sodium-Glucose Transporter 2 | 2022 |
Ferulic acid mitigates diabetic cardiomyopathy via modulation of metabolic abnormalities in cardiac tissues of diabetic rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fructose; Metformin; Oxidative Stress; Rats | 2023 |
Metformin alleviates long-term high-fructose diet-induced skeletal muscle insulin resistance in rats by regulating purine nucleotide cycle.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylosuccinate Synthase; AMP-Activated Protein Kinases; Animals; Antioxidants; Diet; Fructose; Insulin; Insulin Resistance; Metabolic Syndrome; Metformin; Muscle, Skeletal; NF-E2-Related Factor 2; Purine Nucleotides; Rats | 2022 |
Tert-butylhydroquinone abrogates fructose-induced insulin resistance in rats via mitigation of oxidant stress, NFkB-mediated inflammation in the liver but not the skeletal muscle of high fructose drinking rats.
Topics: Animals; Fructose; Inflammation; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; Muscle, Skeletal; Oxidants; Rats | 2022 |
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing.
Topics: Anti-Obesity Agents; Atorvastatin; Drug Approval; Drug Repositioning; Female; Fructose; Humans; Male; Metformin; Obesity; Phentermine; Pregnancy; Topiramate | 2022 |
ChREBP-β/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carrier Proteins; Epithelial Cells; Ferroptosis; Fructose; Glucose; Kidney Tubules; Metformin; Mice; Proteomics; Thioredoxins | 2023 |
Scopoletin Improves Glucose Homeostasis in the High-Fructose High-Fat Diet-Induced Diabetes Model in Wistar Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diet, High-Fat; Fructose; Glucose; Homeostasis; Hypoglycemic Agents; Insulin Resistance; Metformin; Rats; Rats, Wistar; Scopoletin | 2023 |